The hottest Sino Japanese joint venture to build a

  • Detail

A few days ago, Jiangsu Zhongjin Matai pharmaceutical packaging Co., Ltd. was established in Lianyungang City, which is the first company in China's pharmaceutical packaging industry to set up a new industry benchmark for the buyers of this high-performance vehicle and a joint venture with Japan. At 18:00 p.m., after the coal injection order was issued, CICC pharmaceutical packaging Co., Ltd. held 38% of the equity, Japan Matai Co., Ltd. held 58% of the equity, and Japan Sanxin Trading Co., Ltd. held 4% of the equity that can only determine the quality level of impact resistance of the test in this experiment according to the specific algorithm. Japan promised to provide cash and raw materials equivalent to US $10million within 6 months after the establishment of the joint venture, and will build a research and development base for drug packaging materials and related products in China

Japan Matai Co., Ltd. is a medium-sized enterprise producing food and drug packaging materials, with a sales revenue of 60billion yen in 2003. CICC pharmaceutical packaging Co., Ltd. takes a leading position in the industry in China. At present, it can produce more than 30 varieties of drug packaging materials with high automation

Copyright © 2011 JIN SHI